title: Inotropic responsiveness of the heart in catecholamine cardiomyopathy.
abstract: Inotropic responsiveness to norepinephrine (NE) or Ca2+ was studied in 15 rabbits with catecholamine cardiomyopathy (CM) and the results were compared with 11 controls. The former group was prepared by infusing NE (2 micrograms/min/kg) for 90 minutes, 2 to 3 days prior to study, and injury was confirmed and quantified histologically. Comparison of NE dose-response curves relating percent increase of left ventricular (LV) dP/dt max to NE dose in six controls and 10 CM hearts revealed significant depression of CM contractility. Responses to graded infusions of Ca2+ were also determined in five controls and in five CM animals. With the increases in serum Ca2+ identical in the two groups, the percent increases in dP/dt max were less in CM hearts. Further, NE dose-response curves obtained during continuous CaCl2 infusion were sharply attenuated in CM hearts and initial LV end-diastolic pressure (LVEDP) in the CM hearts was considerably higher than in the controls. It is concluded that inotropic sensitivity to NE is reduced in CM hearts. This cannot be ascribed to altered beta-receptors alone, because responsiveness to Ca2+ was also reduced. Myocardial damage was indicated by histology and elevated LVEDP. Moreover, the normalized percent data suggest tht the remaining viable fibers in the CM hearts were functioning subnormally and thus reduced performance was not due solely to the decreased number of contracting units.
mesh_terms: D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002118:Calcium / Q000097:blood; D009202:Cardiomyopathies / Q000139:chemically induced*; D002395:Catecholamines; D004305:Dose-Response Relationship, Drug; D006339:Heart Rate / Q000187:drug effects; D006352:Heart Ventricles / Q000187:drug effects / Q000473:pathology; D009200:Myocardial Contraction / Q000187:drug effects*; D009638:Norepinephrine / Q000494:pharmacology; D011817:Rabbits
chemical_list: D002395:Catecholamines; D002118:Calcium; D009638:Norepinephrine